Galmed Pharmaceuticals Ltd. ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological therapeutics, announced today that the first set of ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...